Novartis AG (NVS)

AI Score

Unlock

112.12

-1.09 (-0.96%)

At close: Mar 21, 2025, 3:59 PM

109.62

-2.23%

After-hours: Mar 21, 2025, 08:00 PM EDT

Novartis AG Income Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04	FY03	FY02	FY01	FY00	FY99	FY98
Revenue	51.72B	46.66B	51.83B	52.88B	49.9B	48.68B	53.17B	50.13B	49.44B	50.39B	53.63B	58.83B	57.56B	59.38B	51.56B	45.1B	42.58B	38.95B	36.75B	32.53B	28.25B	24.86B	23.15B	19.34B	21.83B	20.42B	23.04B
Cost of Revenue	12.83B	12.47B	15.49B	15.87B	15.12B	14.43B	18.41B	17.18B	17.52B	17.4B	17.34B	19.61B	18.76B	18.98B	14.49B	12.18B	11.44B	11.03B	10.3B	8.87B	6.63B	5.89B	5.44B	4.76B	6.25B	5.23B	7.31B
Gross Profit	38.9B	34.19B	36.34B	37.01B	34.78B	34.25B	34.76B	32.96B	31.92B	32.98B	36.29B	39.22B	38.8B	40.39B	37.07B	32.92B	31.14B	27.91B	26.45B	23.66B	21.62B	18.97B	17.71B	14.58B	15.59B	15.19B	15.73B
Operating Income	14.54B	9.77B	9.2B	26.95B	10.15B	9.09B	8.17B	8.63B	8.27B	8.98B	11.09B	10.91B	11.51B	11B	11.53B	9.98B	8.96B	6.78B	7.95B	6.91B	6.54B	5.89B	5.63B	4.39B	4.81B	4.62B	5.35B
Interest Income	568M	627M	379M	71M	91M	245M	294M	110M	43M	33M	33M	34M	50M	62M	103M	156M	306M	423M	367M	405M	388M	323M	416M	293M	n/a	n/a	n/a
Pretax Income	13.64B	9.12B	8.37B	26.14B	9.88B	8.94B	13.84B	9B	7.82B	8.13B	12.27B	10.73B	11.24B	10.77B	11.7B	9.92B	9.5B	7.49B	8.3B	7.26B	6.91B	6.07B	6.29B	5.11B	5.5B	5.34B	5.79B
Net Income	11.94B	14.85B	6.96B	24.02B	8.07B	7.15B	12.61B	7.7B	6.71B	17.78B	10.21B	9.18B	9.51B	9.11B	9.79B	8.4B	8.2B	11.95B	7.17B	6.13B	5.77B	5.02B	5.22B	4.24B	4.39B	4.19B	4.41B
Selling & General & Admin	12.57B	12.49B	14.25B	14.89B	14.2B	14.37B	16.47B	15B	14.19B	14.25B	14.99B	17.61B	17.29B	18.05B	15.8B	14.33B	14.1B	13.26B	12.41B	11.54B	10.41B	9.32B	8.98B	7.66B	7.94B	6.95B	7.68B
Research & Development	10.02B	11.37B	10B	9.54B	8.98B	9.4B	9.07B	8.97B	9.04B	8.94B	9.09B	9.85B	9.33B	9.58B	9.07B	7.47B	7.22B	6.43B	5.35B	4.85B	4.21B	3.76B	3.1B	2.53B	2.84B	2.67B	2.71B
Other Expenses	1.76B	559M	2.9B	895M	1.45B	1.4B	1.04B	362M	417M	824M	1.12B	852M	672M	1.76B	680M	1.14B	867M	1.45B	741M	363M	463M	n/a	n/a	n/a	n/a	949M	n/a
Operating Expenses	24.35B	24.42B	27.14B	25.32B	24.63B	25.17B	26.59B	24.33B	23.65B	24.01B	25.2B	28.31B	27.29B	29.39B	25.55B	22.94B	22.18B	21.13B	18.5B	16.75B	15.08B	13.08B	12.08B	10.18B	10.78B	10.57B	10.39B
Interest Expense	1.01B	855M	837M	811M	869M	850M	957M	777M	707M	655M	704M	683M	724M	751M	692M	551M	290M	237M	266M	294M	261M	243M	259M	218M	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	12.86B	12B	11.77B	12.38B	14.55B	14.35B	15.08B	13.32B	12.05B	11.85B	11.13B	10.45B	9.8B	8.87B	9.32B	n/a	n/a	n/a	n/a	6.39B
Cost & Expenses	37.18B	36.89B	42.63B	41.19B	39.75B	39.59B	45B	41.51B	41.17B	41.41B	42.55B	47.92B	46.05B	48.38B	40.03B	35.12B	33.62B	32.17B	28.8B	25.62B	21.71B	18.98B	17.52B	14.94B	17.03B	15.8B	17.69B
Income Tax	1.7B	551M	1.42B	2.12B	1.81B	1.79B	1.22B	1.3B	1.12B	1.11B	1.54B	1.44B	1.63B	1.53B	1.73B	1.47B	1.34B	947M	1.28B	1.12B	1.13B	1.01B	1.06B	869M	1.11B	1.15B	1.37B
Shares Outstanding (Basic)	2B	2.08B	2.18B	2.24B	2.28B	2.29B	2.32B	2.35B	2.38B	2.4B	2.43B	2.44B	2.42B	2.38B	2.29B	2.27B	2.27B	2.32B	2.35B	2.33B	2.36B	2.38B	2.52B	2.57B	2.63B	2.62B	2.74B
Shares Outstanding (Diluted)	2.04B	2.09B	2.2B	2.26B	2.3B	2.32B	2.34B	2.37B	2.4B	2.44B	2.47B	2.48B	2.44B	2.41B	2.3B	2.28B	2.28B	2.33B	2.36B	2.34B	2.37B	2.41B	2.57B	2.58B	2.63B	2.62B	2.74B
EPS (Basic)	5.97	7.15	3.19	10.71	3.54	3.12	5.44	3.28	2.82	7.40	4.21	3.76	3.93	3.75	4.28	3.70	3.62	5.15	3.06	2.63	2.28	1.99	1.88	1.49	1.70	0.62	0.33
EPS (Diluted)	5.87	7.10	3.17	10.63	3.52	3.08	5.38	3.25	2.80	7.29	4.13	3.70	3.89	3.70	4.26	3.69	3.59	5.13	3.04	2.62	2.27	1.97	1.84	1.49	1.70	0.62	0.33
EBITDA	20.71B	18.29B	14.73B	17.13B	15.24B	15.01B	14.13B	13.9B	13.19B	14.36B	17.66B	15.89B	16.92B	17.09B	15.81B	12.77B	12.46B	10.58B	10.18B	8.78B	7.97B	7.26B	5.9B	4.41B	5.63B	5.56B	6.35B
Depreciation & Amortization	6.07B	8.28B	6.71B	5.43B	5.11B	5.83B	5.21B	5.21B	5.35B	5.58B	4.75B	4.99B	4.95B	5.79B	3.42B	2.3B	2.67B	2.86B	1.99B	1.72B	1.34B	1.28B	690M	585M	918M	949M	1.01B